Douglas Hay
General Counsel bei TENAX THERAPEUTICS, INC.
Profil
Douglas Hay was the founder of Phyxius Pharma, Inc. (founded in 2010) where he held the title of Vice President-Regulatory Affairs from 2010 to 2013.
He is currently working at Tenax Therapeutics, Inc. as Senior Vice President-Regulatory Affairs since 2013.
Previously, he worked at Bristol Myers Squibb Co. from 1999 to 2005 as Vice President-Global Regulatory Sciences.
Dr. Hay completed his graduate degree from The California State University in 1978, his doctorate degree from Northern Arizona University in 1983, and his undergraduate degree from the University of California, Riverside in 1975.
Aktive Positionen von Douglas Hay
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAX THERAPEUTICS, INC. | General Counsel | 14.11.2013 |
Ehemalige bekannte Positionen von Douglas Hay
| Unternehmen | Position | Ende |
|---|---|---|
Phyxius Pharma, Inc.
 Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Gründer | 01.11.2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.03.2005 |
Ausbildung von Douglas Hay
| University of California, Riverside | Undergraduate Degree |
| The California State University | Graduate Degree |
| Northern Arizona University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Phyxius Pharma, Inc.
Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Health Technology |
